Trials / Completed
CompletedNCT00092651
A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, "Factorial" Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet in Patients With Primary Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,398 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the lipid lowering effects of an investigational drug in patients with hypercholesterolemia (high cholesterol).
Detailed description
The duration of treatment is 4 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653A, ezetimibe (+) simvastatin | |
| DRUG | Comparators: simvastatin and ezetimibe |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2003-06-01
- Completion
- 2003-06-01
- First posted
- 2004-09-28
- Last updated
- 2024-08-23
Source: ClinicalTrials.gov record NCT00092651. Inclusion in this directory is not an endorsement.